TY - JOUR
T1 - HDL-apoA-I Exchange
T2 - Rapid Detection and Association with Atherosclerosis
AU - Borja, Mark S.
AU - Zhao, Lei
AU - Hammerson, Bradley
AU - Tang, Chongren
AU - Yang, Richard
AU - Carson, Nancy
AU - Fernando, Gayani
AU - Liu, Xiaoqin
AU - Budamagunta, Madhu S.
AU - Genest, Jacques
AU - Shearer, Gregory C.
AU - Duclos, Franck
AU - Oda, Michael N.
PY - 2013/8/28
Y1 - 2013/8/28
N2 - High density lipoprotein (HDL) cholesterol levels are associated with decreased risk of cardiovascular disease, but not all HDL are functionally equivalent. A primary determinant of HDL functional status is the conformational adaptability of its main protein component, apoA-I, an exchangeable apolipoprotein. Chemical modification of apoA-I, as may occur under conditions of inflammation or diabetes, can severely impair HDL function and is associated with the presence of cardiovascular disease. Chemical modification of apoA-I also impairs its ability to exchange on and off HDL, a critical process in reverse cholesterol transport. In this study, we developed a method using electron paramagnetic resonance spectroscopy (EPR) to quantify HDL-apoA-I exchange. Using this approach, we measured the degree of HDL-apoA-I exchange for HDL isolated from rabbits fed a high fat, high cholesterol diet, as well as human subjects with acute coronary syndrome and metabolic syndrome. We observed that HDL-apoA-I exchange was markedly reduced when atherosclerosis was present, or when the subject carries at least one risk factor of cardiovascular disease. These results show that HDL-apoA-I exchange is a clinically relevant measure of HDL function pertinent to cardiovascular disease.
AB - High density lipoprotein (HDL) cholesterol levels are associated with decreased risk of cardiovascular disease, but not all HDL are functionally equivalent. A primary determinant of HDL functional status is the conformational adaptability of its main protein component, apoA-I, an exchangeable apolipoprotein. Chemical modification of apoA-I, as may occur under conditions of inflammation or diabetes, can severely impair HDL function and is associated with the presence of cardiovascular disease. Chemical modification of apoA-I also impairs its ability to exchange on and off HDL, a critical process in reverse cholesterol transport. In this study, we developed a method using electron paramagnetic resonance spectroscopy (EPR) to quantify HDL-apoA-I exchange. Using this approach, we measured the degree of HDL-apoA-I exchange for HDL isolated from rabbits fed a high fat, high cholesterol diet, as well as human subjects with acute coronary syndrome and metabolic syndrome. We observed that HDL-apoA-I exchange was markedly reduced when atherosclerosis was present, or when the subject carries at least one risk factor of cardiovascular disease. These results show that HDL-apoA-I exchange is a clinically relevant measure of HDL function pertinent to cardiovascular disease.
UR - http://www.scopus.com/inward/record.url?scp=84883180605&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883180605&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0071541
DO - 10.1371/journal.pone.0071541
M3 - Article
C2 - 24015188
AN - SCOPUS:84883180605
SN - 1932-6203
VL - 8
JO - PloS one
JF - PloS one
IS - 8
M1 - e71541
ER -